Cargando…
Acute pleiotropic effects of dapagliflozin in type 2 diabetic patients with heart failure with reduced ejection fraction: a crossover trial
AIMS: This study aimed to explore the rapid effects of dapagliflozin in heart failure with reduced ejection fraction (HFrEF). METHODS AND RESULTS: We studied the functional, echocardiographic, electrophysiological, lung ultrasound, ambulatory blood pressure (BP), microvascular and macrovascular func...
Autores principales: | Ilyas, Fahmida, Jones, Lynette, Tee, Su Ling, Horsfall, Matthew, Swan, Amy, Wollaston, Fiona, Hecker, Tracy, De Pasquale, Carla, Thomas, Simeoni, Chong, William, Stranks, Steve, Mangoni, Arduino A., Selvanayagam, Joseph B., Chew, Derek P., De Pasquale, Carmine G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497349/ https://www.ncbi.nlm.nih.gov/pubmed/34382353 http://dx.doi.org/10.1002/ehf2.13553 |
Ejemplares similares
-
Relationship between Vitamin D Status and Autonomic Nervous System Activity
por: Burt, Morton G., et al.
Publicado: (2016) -
Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?
por: Williams, David M., et al.
Publicado: (2020) -
Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction
por: Isaza, Nicolas, et al.
Publicado: (2021) -
Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
por: Blair, Hannah A.
Publicado: (2021) -
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
por: Vardeny, Orly, et al.
Publicado: (2022)